The Procter & Gamble Company (NYSE:PG – Free Report) – Equities researchers at DA Davidson cut their Q2 2025 EPS estimates for shares of Procter & Gamble in a research note issued to investors on Tuesday, November 26th. DA Davidson analyst L. Weiser now forecasts that the company will post earnings of $1.87 per share for the quarter, down from their prior forecast of $1.93. DA Davidson currently has a “Buy” rating and a $209.00 price target on the stock. The consensus estimate for Procter & Gamble’s current full-year earnings is $6.96 per share. DA Davidson also issued estimates for Procter & Gamble’s FY2025 earnings at $7.03 EPS and FY2026 earnings at $7.49 EPS.
Procter & Gamble (NYSE:PG – Get Free Report) last released its earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The company had revenue of $21.74 billion for the quarter, compared to the consensus estimate of $21.99 billion. During the same quarter in the previous year, the company earned $1.83 EPS. Procter & Gamble’s quarterly revenue was down .6% compared to the same quarter last year.
Check Out Our Latest Stock Report on Procter & Gamble
Procter & Gamble Stock Up 0.0 %
Procter & Gamble stock opened at $179.34 on Wednesday. The company has a market capitalization of $422.35 billion, a PE ratio of 30.92, a PEG ratio of 3.82 and a beta of 0.42. The firm’s fifty day moving average is $170.22 and its 200 day moving average is $168.90. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50. Procter & Gamble has a 12-month low of $142.50 and a 12-month high of $180.43.
Institutional Investors Weigh In On Procter & Gamble
Several institutional investors have recently added to or reduced their stakes in PG. Franklin Resources Inc. lifted its holdings in shares of Procter & Gamble by 10.2% in the third quarter. Franklin Resources Inc. now owns 18,988,721 shares of the company’s stock worth $3,290,573,000 after buying an additional 1,760,214 shares in the last quarter. Asset Advisors Investment Management LLC lifted its holdings in shares of Procter & Gamble by 0.3% in the third quarter. Asset Advisors Investment Management LLC now owns 50,887 shares of the company’s stock worth $8,814,000 after buying an additional 174 shares in the last quarter. Synovus Financial Corp lifted its holdings in shares of Procter & Gamble by 3.4% in the third quarter. Synovus Financial Corp now owns 185,134 shares of the company’s stock worth $32,065,000 after buying an additional 6,077 shares in the last quarter. Destination Wealth Management lifted its holdings in shares of Procter & Gamble by 0.7% in the third quarter. Destination Wealth Management now owns 55,058 shares of the company’s stock worth $9,536,000 after buying an additional 392 shares in the last quarter. Finally, Wilmington Savings Fund Society FSB lifted its holdings in shares of Procter & Gamble by 505.6% in the third quarter. Wilmington Savings Fund Society FSB now owns 645,475 shares of the company’s stock worth $111,796,000 after buying an additional 538,889 shares in the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.
Insider Activity at Procter & Gamble
In other Procter & Gamble news, insider Balaji Purushothaman sold 12,800 shares of the company’s stock in a transaction dated Thursday, November 21st. The shares were sold at an average price of $172.73, for a total transaction of $2,210,944.00. Following the sale, the insider now directly owns 11,595 shares of the company’s stock, valued at $2,002,804.35. This represents a 52.47 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Jon R. Moeller sold 7,007 shares of the company’s stock in a transaction dated Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total transaction of $1,202,751.55. Following the sale, the chief executive officer now directly owns 269,172 shares in the company, valued at approximately $46,203,373.80. This trade represents a 2.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 35,233 shares of company stock worth $6,024,234. 0.18% of the stock is owned by company insiders.
Procter & Gamble Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were given a dividend of $1.0065 per share. The ex-dividend date was Friday, October 18th. This represents a $4.03 annualized dividend and a yield of 2.24%. Procter & Gamble’s payout ratio is currently 69.48%.
About Procter & Gamble
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
See Also
- Five stocks we like better than Procter & Gamble
- How to Invest in the Best Canadian Stocks
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- How to Find Undervalued Stocks
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.